GlaxoSmithKline Shares Up After Avandia Ruling
GlaxoSmithKline's ( GSK ) shares climbed 2.2% in pre-market trading after a majority of the U.S. Food and Drug Administration's panel voted to keep its controversial type 2 diabetes drug Avandia on the U.S. market, albeit with new restrictions. The diabetes drug already carries a black box label warning on elevated cardiac risk. The vote is not a decision. The regulatory authority still has to make... Continue reading GlaxoSmithKline Shares Up After Avandia Ruling GlaxoSmithKline Shares Up After Avandia Ruling originally appeared on DailyFinance on Thu, 15 Jul 2010 08:12:00. Filed Under: Company News , Investing , Health Care , GlaxoSmithKline , Stocks in the News Permalink | Tweet this! | Comments
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here